Eagle Pharmaceuticals Inc (EGRX)
4.13
-0.03
(-0.72%)
USD |
NASDAQ |
Apr 29, 14:38
Eagle Pharmaceuticals Cash from Financing (Quarterly): -6.411M for June 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -6.411M |
| March 31, 2023 | 12.65M |
| December 31, 2022 | 2.389M |
| September 30, 2022 | 3.296M |
| June 30, 2022 | -0.536M |
| March 31, 2022 | -11.36M |
| December 31, 2021 | -10.11M |
| September 30, 2021 | -10.04M |
| June 30, 2021 | -5.22M |
| March 31, 2021 | -3.02M |
| December 31, 2020 | -6.116M |
| September 30, 2020 | -23.96M |
| June 30, 2020 | -114.85M |
| March 31, 2020 | 107.06M |
| December 31, 2019 | -4.105M |
| September 30, 2019 | -1.227M |
| June 30, 2019 | -16.24M |
| March 31, 2019 | -2.656M |
| December 31, 2018 | -50.46M |
| September 30, 2018 | -12.68M |
| June 30, 2018 | -1.09M |
| March 31, 2018 | -23.89M |
| Date | Value |
|---|---|
| December 31, 2017 | -6.079M |
| September 30, 2017 | 35.85M |
| June 30, 2017 | -9.665M |
| March 31, 2017 | -12.00M |
| December 31, 2016 | -18.43M |
| September 30, 2016 | -15.24M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.386M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.167M |
| March 31, 2015 | 55.26M |
| December 31, 2014 | 0.034M |
| September 30, 2014 | 0.0651M |
| June 30, 2014 | -0.4182M |
| March 31, 2014 | 47.01M |
| December 31, 2013 | -0.498M |
| September 30, 2013 | -0.0197M |
| June 30, 2013 | 9.911M |
| March 31, 2013 | -0.0825M |
| December 31, 2012 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-114.85M
Minimum
Jun 2020
107.06M
Maximum
Mar 2020
-5.165M
Average
-5.22M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| Inspire Medical Systems Inc | -10.12M |
| Soligenix Inc | -0.0462M |
| Marinus Pharmaceuticals Inc | 0.661M |
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.126M |
| Cash from Investing (Quarterly) | -0.006M |